My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2014
Top Stories
President Requests Increased Funding on Antimicrobial Resistance
IDSA Calls for Further Strengthening of Overall ID Programs
President Obama’s fiscal year 2015 budget proposal includes a number of funding requests that would strengthen the nation’s response to antimicrobial resistance and other infectious disease threats. But IDSA believes that more leadership is needed, particularly in light of budget cuts that have taken effect in recent years as a result of sequestration.

Among other things, the President’s budget would:
  • more than double the funding for the Centers for Disease Control and Prevention (CDC) efforts to address antimicrobial resistance
  • continue funding for the Advanced Molecular Detection initiative to better track  emerging infectious diseases, antimicrobial resistance, and the spread of pathogens in the U.S.
  • fund the Global Health Security initiative to detect, prevent, and control infectious diseases around the world
  • increase funding for pandemic influenza activities, including vaccine production, countermeasure stockpiling, and antiviral drug development.  
While IDSA supports these aspects of the President’s proposed budget, the Society also expressed concern over recent years of deep budget cuts and their devastating impact on our nation’s biomedical research enterprise and public health infrastructure. IDSA encouraged the administration to work with Congress to reverse the damage of years of inadequate funding by making significant investments, particularly at the National Institutes of Health, which has faced a trend of decreasing purchasing power seen since FY 2004. Take Action by sending the word to members of Congress that public health and biomedical research components of the federal budget need funding.

< Previous Article |

Post a comment

Your name:

Your comment:

Clinical Practice Management
Exceptions and Appeals: How to Challenge Adverse Health Plan Coverage Decisions
Upcoming PQRS Milestones: March 31 Deadline
Policy and Advocacy
DISARM Act Would Provide Supplemental Payment for Antimicrobials
Informed Consent for Specimen Use: IDSA Expresses Concern Over Proposed Rule
HIVMA Members Oppose Anti-Homosexuality Laws
IDSA Comments on FDA Draft Guidance on FMT
Proposed Federal Policy Could Lead to Wider Screening for HBV
Science Speaks Blog
The Center for Global Health Policy’s Blog, Science Speaks, covered a Day of Action at the Nigeria Embassy, important news from the Conference on Retroviruses and Opportunistic Infections (CROI), and other important developments in global HIV news
Education and Resources
Maintenance of Certification Program Changes Now in Effect: Enroll by March 31
GME Accreditation for MDs and DOs to be Unified Over the Next Five Years
Hepatitis C Webinar Series Archives: New Presentation Available
You and Your Colleagues
In Memoriam: Albert Z. Kapikian, MD, FIDSA (1931-2014)
Call For Nominations for the IDSA Board of Directors Deadline: April 1
Nominate Your Colleague for a 2014 Society Award Deadline: April 1
Members on the Move
New Members
Top Stories
From the President: IDSA Volunteers Build on the Momentum of Antimicrobial Resistance Efforts
CDC Reports Wide Variation in Prescribing Practices
Journal Club
President Requests Increased Funding on Antimicrobial Resistance
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.